Changzhou Trendi Medical Technology Co., Ltd is invested and established by the project team of Patrick Kwan (Professor of the Department of Neuroscience of Monash University, academician of Australian Academy of Medicine and Science), Jiangsu Industrial Technology Research Institute, and Changzhou Science and Education Town Investment and Development Co., Ltd. Trendi is founded on September 30.2020, engaged in the development of clinical rapid in vitro diagnostic system products. Its core project team is a multinational technical team, including the medical academy, semiconductor postdoctoral, biology postdoctoral, and engineering talents from Huawei, Qualcomm, and Apple.

The company is headquartered in Changzhou Science and Education Town and established a wholly-owned R&D subsidiary in Melbourne, Australia. The main business includes four platforms: reagent development platform, chip test strip development platform, detection instrument development platform, and epilepsy drug selection AI diagnosis platform. Through cutting-edge technology, we provide customers with complete product solutions, fast and efficient diagnostic methods for the rapidly developing precision medical market, and benefit mankind.

The company has a total area of 1,600 square meters, including 250 square meters of office area, 1,350 square meters of laboratory area and production area with 500 square meters of 10,000 and 100,000 clean areas. The laboratories include  microfluidics laboratory, molecular biology laboratory, electronic laboratory and other functional laboratories. At present, it has been equipped with more than 30 professional experimental equipments. The production area has a reagent production area, a microfluidic chip production area, a biosensor chip area and an assembly area, and a detection area.